| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.096 | 0.07 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.083 | 0.08 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.081 | 0.09 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.031 | 0.5 |